CAPTAIN OF INDUSTRY
African Pharma Review takes a look at the industry's groundbreakers, the shapeshifters, the industry captains, the emerging stars to watch and the leading voices moving the industry forward for the African continent.
CEO & vICE pRESIDENT, MERC RESEARCH
Yvette Erasmus as the CEO and Vice President of MERC Research Inc. has extensive knowledge and experience within the healthcare industry that extends beyond the borders of South Africa. She is a patron for clinical research and her invaluable contribution is recognized across the globe. Being part of the Clinical Trial Site in Middelburg she has helped the team to acquire two SPRIA (Site Patient Recruitment Innovation Award) awards (2015 and 2019) by SCRS (Society for Clinical Research Sites). Raising clinical trial awareness in local communities continues to be her passion; this is orchestrated through her involvement in developing Community Advisory Boards and Youth Advisory Boards to become advocates on clinical trials in the communities.
SACRA (South African Clinical Research Association) is a non-profit organisation representing the clinical research industry in South Africa. The association provides a forum for information-sharing, networking and the exchange of ideas. SACRA has elected Yvette to form part of the EXCO team to be a voice for the South African Trial Industry. This membership contributes towards a greater goal which aims to turn South Africa into the number one Clinical Trials destination. The African continent with its vast diversity in terms of age, gender, ethnicity, race and genetics, is what the clinical trial industry needs. Yvette believes in and drives her work ethic towards making Africa the chosen continent for future clinical trials as she ironically states, “Africa can and must become the number one trial destination in the world.”